Compliance
Medical
Medical market entry should begin with the exact product, intended use, claims, technology and manufacturing model. These facts shape classification, evidence, registration work, local responsibilities, quality arrangements and the time and capital required before commercial activity can begin.
Preparing Medical Products for China Market Access
01
Define the regulated product
Create a controlled description covering intended use, users, operating principle, models, accessories, claims and manufacturing sites. Marketing language and regulatory documentation should refer to the same product.
Product definition: Intended use / Technology / Models / Claims / Manufacturer
02
Confirm the regulatory route and owner
Identify the proposed classification, application route, responsible entities and critical evidence. Assumptions should be recorded for specialist review before budget and launch timing are approved.
Route record: Classification / Applicant / Evidence / Local responsibility
From Intended Use to Commercial Readiness
03
Assess evidence and quality readiness
Map available technical, performance, clinical and quality information against the proposed route. Gaps should have owners, cost estimates and an effect on the commercial timetable.
Evidence plan: Technical / Performance / Clinical / Quality / Gap owner
04
Plan the product lifecycle
Registration is followed by change control, supply oversight, complaints, safety monitoring and ongoing records. The operating model should assign these responsibilities before launch.
Lifecycle map: Change / Supply / Complaint / Safety / Renewal
Regulatory Decisions Before Investment
Guide
Guidance on product definition, classification, evidence, registration planning, quality responsibilities, commercial readiness and lifecycle control.
Comparison
Comparisons of product, registration and market-access routes across evidence, control, timing, cost, local responsibility and commercial fit.
Review
Reviews of intended use, claims, classification assumptions, technical evidence, quality systems, manufacturing information and lifecycle readiness.
FAQ
Answers to management questions on classification, applicant roles, evidence, testing, manufacturing, registration timing, changes and post-market work.
Resources
Product definitions, evidence maps, responsibility matrices, document lists and readiness records for regulatory and commercial teams.
Tool
Tools for classification assessment, evidence-gap review, route comparison, budget planning and pre-submission readiness.
Case
Examples of how foreign medical businesses defined products, resolved evidence gaps and coordinated regulatory work with commercial plans.
News
Developments affecting medical products, regulatory administration, evidence expectations and the assumptions behind China market access.
How to Use the China Medical Compliance Hub
Use Guide to frame the work, Comparison and Review to test alternatives and risk, and FAQ and Resources to prepare the working file. Tool and Case support the management recommendation; News confirms whether the underlying assumptions remain current.
Management should approve the product definition, route assumptions, evidence plan, responsible parties and lifecycle budget before major investment. Regulatory specialists should confirm current requirements for the specific product, with material changes returned to the business case.